Non-human primate study generates information relevant to HIV-1 vaccine strategies

Aug 02, 2010

Monkeys repeatedly immunized with a particular form the HIV-1 envelope glycoprotein generated antibodies capable of neutralizing diverse strains of HIV-1, according to a paper published online in the Journal of Experimental Medicine on August 2.

Antibodies in the blood of monkeys immunized with a HIV-1 envelope trimer neutralized a broader variety of HIV-1 strains than in the blood of humans immunized with an HIV-1 envelope monomer during the VAX04 phase III clinical trial.

However, the immunized monkeys showed only weak protection against subsequent rectal infection with a simian virus. This weak protection may be due to the fact that neutralizing antibody titers were at least 1,000-fold lower in rectal and vaginal tissues than in the blood.

These findings suggest that methods to boost neutralizing antibody abundance in rectal and vaginal tissues might be needed to better prevent HIV-1 transmission.

Explore further: Taking a look at the dark side of tourism in the Dominican Republic

More information: Sundling, C., et al. 2010. J. Exp. Med. doi:10.1084/jem.20100025

Related Stories

HIV isolate from Kenya provides clues for vaccine design

Jan 02, 2008

Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.

Exhausted B cells fail to fight HIV

Jul 14, 2008

HIV tires out the cells that produce virus-fighting proteins known as antibodies, according to a human study that will be published online July 14 in the Journal of Experimental Medicine.

Recommended for you

More HIV+ patients undergoing spinal fusion

Sep 25, 2014

(HealthDay)—More HIV-positive patients are undergoing spinal fusions, and these patients have higher rates of complications resulting from the procedures, according to a study published in the Sept. 15 ...

User comments : 0